Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 288

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis

Open access
Kontou, Panagiota I., Braliou, Georgia G., Dimou, Niki L., Nikolopoulos, Georgios, Bagos, Pantelis G.·2020·Diagnostics

Published version of a preprint

Abstract

The emergence of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 made imperative the need for diagnostic tests that can identify the infection. Although Nucleic Acid Test (NAT) is considered to be the gold standard, serological tests based on antibodies could be very helpful. However, individual studies are usually inconclusive, thus, a comparison of different tests is needed. We performed a systematic review and meta-analysis in PubMed, medRxiv and bioRxiv. We used the bivariate method for meta-analysis of diagnostic tests pooling sensitivities and specificities. We evaluated IgM and IgG tests based on Enzyme-linked immunosorbent assay (ELISA), Chemiluminescence Enzyme Immunoassays (CLIA), Fluorescence Immunoassays (FIA), and the Lateral Flow Immunoassays (LFIA). We identified 38 studies containing data from 7848 individuals. Tests using the S antigen are more sensitive than N antigen-based tests. IgG tests perform better compared to IgM ones and show better sensitivity when the samples were taken longer after the onset of symptoms. Moreover, a combined IgG/IgM test seems to be a better choice in terms of sensitivity than measuring either antibody alone. All methods yield high specificity with some of them (ELISA and LFIA) reaching levels around 99%. ELISA- and CLIA-based methods perform better in terms of sensitivity (90%–94%) followed by LFIA and FIA with sensitivities ranging from 80% to 89%. ELISA tests could be a safer choice at this stage of the pandemic. LFIA tests are more attractive for large seroprevalence studies but show lower sensitivity, and this should be taken into account when designing and performing seroprevalence studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/diagnostics10050319

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 10

  1. Du, Z., Zhu, F., Guo, F., Yang, B., and Wang, T. (2020). Detection of antibodies against SARS-CoV-2 in patients with COVID-19. J. Med. Virol. · doi:10.1002/jmv.25820
  2. Xu, Y. (2020). Dynamic profile of severe or critical COVID-19 cases. medRxiv. · doi:10.1101/2020.03.18.20038513
  3. Wang, Z., Li, H., Li, J., Yang, C., Guo, X., Hu, Z., Chen, Z., Wang, S., and Liu, J. (2020). Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study. medRxiv. · doi:10.1101/2020.03.22.20041285
  4. Lin, D., Liu, L., Zhang, M., Hu, Y., Yang, Q., Guo, J., Dai, Y., Xu, Y., Cai, Y., and Chen, X. (2020). Evaluations of serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. medRxiv. · doi:10.1101/2020.03.27.20045153
  5. Bai, 2020, Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province, Zhonghua Yu Fang Yi Xue Za Zhi Chin. J. Prev. Med., 54, E005
  6. Garcia, F.P., Perez Tanoira, R., Romanyk Cabrera, J.P., Arroyo Serrano, T., Gomez Herruz, P., and Cuadros Gonzalez, J. (2020). Rapid diagnosis of SARS-CoV-2 infection by detecting IgG and IgM antibodies with an immunochromatographic device: A prospective single-center study. medRxiv.
  7. Liu, W., Liu, L., Kou, G., Zheng, Y., Ding, Y., Ni, W., Wang, Q., Tan, L., Wu, W., and Tang, S. (2020). Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2. J. Clin. Microbiol. · doi:10.1101/2020.03.16.20035014
  8. Paradiso, A.V., De Summa, S., Loconsole, D., Procacci, V., Sallustio, A., Centrone, F., Silvestris, N., Cafagna, V., De Palma, G., and Tufaro, A. (2020). Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR. medRxiv.
  9. Zhao, R., Li, M., Song, H., Chen, J., Ren, W., Feng, Y., Song, J.-W., Peng, Y., Su, B., and Guo, X. (2020). Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteins. medRxiv. · doi:10.1101/2020.03.26.20042184
  10. Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., and Xu, Y. (2020). Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. BioRxiv.

Cited by

See all 288

Metadata

Authors
Kontou, P. I., Braliou, G. G., Dimou, N. L., Nikolopoulos, G., & Bagos, P. G.
Venue
Diagnostics
Publisher
MDPI AG
Published
2020-05-19
Volume
10
Issue
5
Pages
319
ISSN
2075-4418 (ISSN-L)
OpenAlex
W3025820218
Cited by
288
References
67
FWCI
3.72
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis. https://app.cochat.ai/papers/10.3390/diagnostics10050319
The paper
Kontou, P. I., Braliou, G. G., Dimou, N. L., Nikolopoulos, G., & Bagos, P. G. (2020). Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis. Diagnostics. https://doi.org/10.3390/diagnostics10050319

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.